Uterotonics, magnesium sulphate and antibiotics during childbirth and peripartum: important obstetric drugs for the anaesthesiologist

M Astete, HJ Lacassie - … de Anestesiología y Reanimación (English Edition), 2024 - Elsevier
The main causes of maternal mortality are comorbidities, hypertensive pregnancy syndrome,
obstetric haemorrhage, and maternal sepsis. For this reason, uterotonics, magnesium …

Uterine Ultrasound Doppler Hemodynamics of Magnesium Sulfate Combined with Labetalol in the Treatment of Pregnancy‐Induced Hypertension Using Empirical …

C Liu, F Wang, X Yin - Computational Intelligence and …, 2022 - Wiley Online Library
The aim of this study was to explore the hemodynamic changes of magnesium sulfate
combined with labetalol in the treatment of pregnancy‐induced hypertension (PIH) under …

Antenatal Low Dose Magnesium Sulphate for Foetal Neuroprotection in Preterm Birth Versus Control: A Comparative Prospective Cohort Study in Tertiary Care Centre …

N Kumar, P Kumar, S Kumar, P Tulsiyan - The Journal of Obstetrics and …, 2023 - Springer
Introduction Preterm infants are at great risk of neurological impairments. This study aimed
to evaluate what is the difference in short-and long-term neonatal outcome comparing …

[HTML][HTML] Neuroprotective effect of magnesium sulfate in premature infants. Analysis after establishing an antenatal administration protocol in a tertiary care hospital

BF Monteagudo, SV Castro, PC García… - Anales de Pediatría …, 2023 - Elsevier
Introduction In 2016, a protocol was developed in our hospital for the antenatal
administration of magnesium sulfate in pregnant women at risk of imminent preterm birth as …

Neonatal magnesium levels are safe after maternal MgSO4 administration: a comparison between unexposed preterm neonates and neonates exposed for fetal …

I Dehaene, T Van Steenstraeten, K De Coen… - European Journal of …, 2022 - Springer
To objective of this study was to compare neonatal magnesemia in the first 15 days of
neonatal life between three groups: a control group not exposed to MgSO4, a …

Association of hypermagnesemia at birth and admission hypothermia in pre-term infants: A secondary analysis of a prospective cohort study

JP Caldas, E Junqueira… - Journal of Neonatal …, 2024 - content.iospress.com
BACKGROUND: Hypothermia on admission is associated with increased mortality in
preterm infants. Drugs administered to pregnant women is implicated in its occurrence …

[HTML][HTML] Efecto neuroprotector del sulfato de magnesio en prematuros. Análisis tras instaurar su protocolo de administración antenatal en un hospital terciario

BF Monteagudo, SV Castro, PC García, SZ Sarrato… - Anales de …, 2023 - Elsevier
Introducción En 2016 se desarrolló en nuestro centro un protocolo de administración
antenatal de sulfato de magnesio en gestantes con riesgo de parto pretérmino inminente …

Magnesium Sulfate Before Preterm Birth for Neuroprotection

ES Shepherd, S Goldsmith, LW Doyle, P Middleton… - 2024 - digital.library.adelaide.edu.au
OBJECTIVE: To systematically review the evidence for the effectiveness and safety of
magnesium sulfate as a fetal neuroprotective agent when given to individuals at risk of …

[PDF][PDF] Comparison of 12 hours versus 24 hours intravenous administration of MgSO4 in the management of eclampsia

S Khan, P Humayun, SN Awan, SB Naqvi, R Mohsin… - PJMHS, 2021 - pjmhsonline.com
Aim: To determine the maternal outcomes in patients receiving 12-hour versus 24-hour
maintenance dose of MgSO4 for the management of eclampsia. Methods: The randomized …

Amenaza de parto prematuro: actitud terapéutica

P Lorain, J Sibiude, G Kayem - EMC-Ginecología-Obstetricia, 2023 - Elsevier
La amenaza de parto prematuro, definida por contracciones uterinas asociadas a
modificaciones cervicales entre las 22 y 37 semanas de amenorrea (SA), es la principal …